0001209191-20-035506.txt : 20200610
0001209191-20-035506.hdr.sgml : 20200610
20200610162157
ACCESSION NUMBER: 0001209191-20-035506
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200608
FILED AS OF DATE: 20200610
DATE AS OF CHANGE: 20200610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bruhn Suzanne Louise
CENTRAL INDEX KEY: 0001517790
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37722
FILM NUMBER: 20954913
MAIL ADDRESS:
STREET 1: C/O AEGLEA BIOTHERAPEUTICS, INC.
STREET 2: 901 S. MOPAC EXPRESSWAY, SUITE 250
CITY: AUSTIN
STATE: TX
ZIP: 78746
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aeglea BioTherapeutics, Inc.
CENTRAL INDEX KEY: 0001636282
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464312787
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 805 LAS CIMAS PARKWAY
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: (512) 942-2935
MAIL ADDRESS:
STREET 1: 805 LAS CIMAS PARKWAY
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78746
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-08
0
0001636282
Aeglea BioTherapeutics, Inc.
AGLE
0001517790
Bruhn Suzanne Louise
C/O AEGLEA BIOTHERAPEUTICS, INC.
805 LAS CIMAS PARKWAY, #100
AUSTIN
TX
78746
1
0
0
0
Director Stock Option (right to buy)
8.89
2020-06-08
4
A
0
28100
0.00
A
2030-06-07
Common Stock
28100
28100
D
The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 8, 2020 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.
/s/ Charles N. York II, by power of attorney
2020-06-10